Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic & Translational -> Basic Science (O)

PET/CT Radiomics predict Pulmonary Lymphangitic Carcinomatosis (PLC) in Non-Small Cell Lung Cancer (NSCLC)

Mario Jreige, Valentin Oreiller, Igor Letovanec, Niklaus Schaefer, Adrien Depeursinge and John Prior
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1311;
Mario Jreige
1Lausanne University Hospital Lausanne Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentin Oreiller
1Lausanne University Hospital Lausanne Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Igor Letovanec
1Lausanne University Hospital Lausanne Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niklaus Schaefer
2CHUV Lausanne Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrien Depeursinge
1Lausanne University Hospital Lausanne Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Prior
3Lausanne University Hospital La Conversion Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1311

Introduction: Pulmonary lymphangitic carcinomatosis (PLC) is defined as the spread of cancer through the lymphatic system into the lung interstitium and its accurate radiologic diagnosis is challenging. We propose and evaluate a PET/CT Radiomics analysis to predict the definitive diagnosis of PLC based on histopathologic examination in NSCLC.

Methods: Ninety patients addressed for initial staging of NSCLC were retrospectively included (PLC 67/90=74%, non-PLC 23/67=26%). This dataset was split into a training set and a validation set. The training set included only images from our institution. The validation set included only images from different medical centers. An initial set of 224 radiomic features were extracted from F-18-FDG PET/CT with QuantImage [1] and PyRadiomics [2], including intensity and 3-D texture features from the tumoral (GTV-T), peritumoral (P-GTV) and contralateral normal lung volumes (NLV). The machine learning pipeline included feature selection, principal component analysis and logistic regression. The pipeline was trained and optimized on the training set for different features subsets from PET and CT for each GTV and for P-GTV minus NLV. Performance averages and confidence intervals [95%CI] were assessed with bootstrap analysis on the validation set.

Results: The following performances were observed for P-GTV for CT (i) and PET (ii): Area Under the ROC Curve (AUC) (i) 0.85 [0.68-0.98], (ii) 0.79 [0.58-0.96], accuracy (i) 0.80 [0.68-0.98], (ii) 0.79 [0.58-0.96], sensitivity (i) 0.77 [0.63-0.93], (ii) 1.00 [1.00-1.00] and specificity (i) 0.75 [0.38-1.00], (ii) 0.26 [0-0.63]. GTV-T and (P-GTV minus NLV) showed an AUC of (i) 0.71 [0.45-0.93], (ii) 0.71 [0.51-0.87] and (i) 0.79 [0.63-0.92], (ii) 0.72 [0.48-0.93], respectively.

Conclusions: These results suggest that FDG-PET/CT Radiomics analysis of the peritumoral NSCLC space can help predict PLC using both CT- and PET-derived features. Our proposed radiomics model may help to probe the peritumoral environment by having the capacity to leverage higher order 3-D textural information that is invisible to the naked eye, thus allowing to predict PLC.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET/CT Radiomics predict Pulmonary Lymphangitic Carcinomatosis (PLC) in Non-Small Cell Lung Cancer (NSCLC)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PET/CT Radiomics predict Pulmonary Lymphangitic Carcinomatosis (PLC) in Non-Small Cell Lung Cancer (NSCLC)
Mario Jreige, Valentin Oreiller, Igor Letovanec, Niklaus Schaefer, Adrien Depeursinge, John Prior
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1311;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PET/CT Radiomics predict Pulmonary Lymphangitic Carcinomatosis (PLC) in Non-Small Cell Lung Cancer (NSCLC)
Mario Jreige, Valentin Oreiller, Igor Letovanec, Niklaus Schaefer, Adrien Depeursinge, John Prior
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1311;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic & Translational -> Basic Science (O)

  • Simplifying thryoid cancer 131I maximum permissible activity estimation
  • Hydroxypropyl β-cyclodextrin as the pharmaceutical excipient for radioiodinated hypericin improves solubility and plasma clearance without affecting netrotic targeting.
  • Functional tumor volume measurement in Ga-DOTATATE PET-CT: Which method is correct?
Show more Oncology: Basic & Translational -> Basic Science (O)

Image Guided Therapy (Poster Session)

  • Effects and safety of alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) compared with 131I-meta-iodobenzylguanidine (131I-MIBG) on tumor growth suppression in a pheochromocytoma mouse model
  • Texture analysis of 18F-choline uptake in prostate gland of patients with untreated cancer: relationship with risk stratification, additional prostate biopsy findings and patient’s outcome
  • New Artificial intelligence model for 18F-Choline PET/CT in evaluation of high-risk prostate cancer outcome: texture analysis and radiomics features classification for prediction of disease progression
Show more Image Guided Therapy (Poster Session)

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire